Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

被引：0
|
作者：
Gauri Mishra
Anouk Dev
Eldho Paul
Wa Cheung
Jim Koukounaras
Ashu Jhamb
Ben Marginson
Beng Ghee Lim
Paul Simkin
Adina Borsaru
James Burnes
Mark Goodwin
Vivek Ramachandra
Manfred Spanger
John Lubel
Paul Gow
Siddharth Sood
Alexander Thompson
Marno Ryan
Amanda Nicoll
Sally Bell
Ammar Majeed
William Kemp
Stuart K. Roberts
机构：
[1] Gastroenterology,School of Public Health and Preventive Medicine
[2] Monash Health,Department of Gastroenterology
[3] Monash University,undefined
[4] Radiology,undefined
[5] Alfred Health,undefined
[6] Radiology,undefined
[7] St. Vincent’s Hospital,undefined
[8] Radiology,undefined
[9] Royal Melbourne Hospital,undefined
[10] Radiology,undefined
[11] Monash Health Eastern Health,undefined
[12] Radiology,undefined
[13] Austin Health,undefined
[14] Radiology,undefined
[15] Eastern Health,undefined
[16] The Alfred Hospital,undefined
[17] Gastroenterology,undefined
[18] Austin Health,undefined
[19] Gastroenterology,undefined
[20] Royal Melbourne Hospital,undefined
[21] Gastroenterology,undefined
[22] St. Vincent’s Hospital,undefined
[23] Gastroenterology,undefined
[24] Eastern Health,undefined
来源：
BMC Cancer | / 20卷
关键词：
Hepatocellular carcinoma; Repeat transarterial chemoembolisation; Prognosis; Alpha-fetoprotein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Low alpha-fetoprotein hepatocellular carcinoma
    Carr, Brian I.
    Pancoska, Petr
    Branch, Robert A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (09) : 1543 - 1549
  • [42] Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study
    Broadhurst, P.
    Toyoda, H.
    Kumada, T.
    Schweitzer, N.
    Vogel, A.
    Benckert, J.
    Berg, T.
    Best, J.
    Dechene, A.
    Weinmann, A.
    Galle, P.
    Yeo, W.
    Chan, S. L.
    Berhane, S.
    Palmer, D.
    Cross, T.
    Stern, N.
    Reeves, H.
    Johnson, P.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S620 - S621
  • [43] Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
    Zhu, Andrew X.
    Finn, Richard S.
    Kang, Yoon-Koo
    Yen, Chia-Jui
    Galle, Peter R.
    Llovet, Josep M.
    Assenat, Eric
    Brandi, Giovanni
    Motomura, Kenta
    Ohno, Izumi
    Daniele, Bruno
    Vogel, Arndt
    Yamashita, Tatsuya
    Hsu, Chih-Hung
    Gerken, Guido
    Bilbruck, John
    Hsu, Yanzhi
    Liang, Kun
    Widau, Ryan C.
    Wang, Chunxiao
    Abada, Paolo
    Kudo, Masatoshi
    [J]. BRITISH JOURNAL OF CANCER, 2021, 124 (08) : 1388 - 1397
  • [44] Alpha-fetoprotein predicts survival and tumor progression in patients with hepatocellular carcinoma treated with sorafenib
    Pinter, Matthias
    Sieghart, Wolfgang
    Graziadei, Ivo
    Vogel, Andreas
    Maieron, Andreas
    Koenigsberg, Robert
    Kornek, Gabriela
    Peck-Radosavljevic, Markus
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A24 - A24
  • [45] Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
    Andrew X. Zhu
    Richard S. Finn
    Yoon-Koo Kang
    Chia-Jui Yen
    Peter R. Galle
    Josep M. Llovet
    Eric Assenat
    Giovanni Brandi
    Kenta Motomura
    Izumi Ohno
    Bruno Daniele
    Arndt Vogel
    Tatsuya Yamashita
    Chih-Hung Hsu
    Guido Gerken
    John Bilbruck
    Yanzhi Hsu
    Kun Liang
    Ryan C. Widau
    Chunxiao Wang
    Paolo Abada
    Masatoshi Kudo
    [J]. British Journal of Cancer, 2021, 124 : 1388 - 1397
  • [46] Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation
    Du, Xi-Lin
    Ma, Qing-Jiu
    Wu, Tao
    Bao, Guo-Qiang
    Lu, Jian-Guo
    Chu, Yan-Kui
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2007, 6 (02) : 172 - 175
  • [47] Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation
    Xi-Lin Du
    [J]. Hepatobiliary & Pancreatic Diseases International, 2007, (02) : 172 - 175
  • [48] Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
    Wei, Zhewen
    Zhang, Yizhou
    Lu, Haizhen
    Ying, Jianming
    Zhao, Hong
    Cai, Jianqiang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (04) : 669 - 677
  • [49] Role of Alpha-Fetoprotein as Predictor of Recurrence in Patients with Hepatocellular Carcinoma Treated with Bridge Therapies before Liver Transplantation
    Lai, Quirino
    Mennini, Gianluca
    Nudo, Francesco
    Spoletini, Gabriele
    Corradini, Stefano Ginanni
    Berloco, Pasquale B.
    Rossi, Massimo
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S218 - S218
  • [50] Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis
    Memon, Khairuddin
    Kulik, Laura
    Lewandowski, Robert J.
    Wang, Edward
    Ryu, Robert K.
    Riaz, Ahsun
    Nikolaidis, Paul
    Miller, Frank H.
    Yaghmai, Vahid
    Baker, Talia
    Abecassis, Michael
    Benson, Al B., III
    Mulcahy, Mary F.
    Omary, Reed A.
    Salem, Riad
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1112 - 1120
12345